CELU

Celularity Inc

CELU.US celularity.com + Research + Basket
CIK 0001752828
Employees 115
Phone 908 768 2170
Fiscal year end December
IPO Aug 08, 2019
Address 170 Park Avenue, Florham Park, NJ, United States, 07932
0.83
-0.02 (-2.27%)
USD · NASDAQ
52-week range
0.56
2.55
Trading at 14% of the 52-week range
Market Cap
27.56M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
-1.21
Div. Yield
N/A
% Institutions
11.39%
% Insiders
33.27%

1 Year

-56.0%

3 Year

-59.6%

10 Year

-99.1%
Description

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Actions

Add an action for CELU.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Robert Joseph Hariri M.D., Ph.D. Founder, CEO & Chairman 1959
Mr. Steven N. Gordon Esq. Chief Operating and Administrative Officer & Director NA
Mr. Carlos Ramirez SVP of Investor Relations NA
Mr. Kyle Harold Fletcher Esq. Chief Legal and Strategy Officer & Corporate Secretary 1985
Sharmila Koppisetti M.D. Senior Vice President of Clinical Dev. Immunology & Drug Safety NA
Mr. Tim Wilk Senior Vice President of Technical Operations NA
Mr. David Jakob Lemus CPA, M.S., MBA Treasurer 1962

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jan 12, 2024 Kok Thay Lim N/A Purchase 2.14M $2.50 $5.35M SEC
Oct 05, 2023 Robert J Hariri N/A Purchase 935.76K $1.60 $1.50M SEC
Sep 29, 2023 Robert J Hariri N/A Purchase 906.45K $1.70 $1.54M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
C V Starr & Co Inc 764.07K Jun 30, 2026 2.35% $0.84 0.00%
Vanguard Capital Management, LLC 621.11K Jun 30, 2026 1.91% $0.00 0.00%
Geode Capital Management, LLC 167.15K Jun 30, 2026 0.52% $0.00 -12.52%
Citadel Advisors Llc 99.05K Jun 30, 2026 0.31% $0.00 0.00%
Vanguard Fiduciary Trust Co 79.87K Jun 30, 2026 0.25% $0.00 0.00%
BlackRock Inc 76.36K Jun 30, 2026 0.24% $0.00 -40.11%
State Street Corp 57.83K Jun 30, 2026 0.18% $0.00 0.00%
HRT FINANCIAL LLC 56.59K Jun 30, 2026 0.17% $0.00 342.67%
Northern Trust Corp 44.16K Jun 30, 2026 0.14% $0.00 0.00%
Biltmore Family Office, LLC 35.00K Jun 30, 2026 0.11% $0.00 0.00%
HB Wealth Management, LLC 31.92K Jun 30, 2026 0.10% $0.00 -21.03%
Keynote Financial Services, LLC 29.92K Jun 30, 2026 0.09% $0.01 2.05%
Jane Street Group LLC 28.71K Jun 30, 2026 0.09% $0.00 0.00%
CenterStar Asset Management, LLC 21.00K Jun 30, 2026 0.06% $0.00 17.65%
Virtu Financial LLC 18.70K Jun 30, 2026 0.06% $0.00 0.00%
Royal Bank of Canada 18.00K Jun 30, 2026 0.06% $0.00 0.00%
Ipg Investment Advisors, LLC 17.17K Jun 30, 2026 0.05% $0.00 0.00%
IFP Advisors, LLC 12.00K Jun 30, 2026 0.04% $0.00 50.00%
Tower Research Capital LLC 5.11K Jun 30, 2026 0.02% $0.00 56.59%
Group One Trading, LLC 3.60K Jun 30, 2026 0.01% $0.00 3,684.21%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 455.05K 1.40% ▲ 0.00% Sep 30, 2026
2 Fidelity Extended Market Index 86.96K 0.27% ▼ 0.53% Aug 31, 2026
3 Fidelity Series Total Market Index 21.18K 0.07% ▲ 0.00% Aug 31, 2026
4 Fidelity Total Market Index 20.68K 0.06% ▲ 0.00% Aug 31, 2026
5 Vanguard U.S. Eq Idx £ Acc 2.32K 0.01% ▲ 0.00% Sep 30, 2026
6 Fidelity Nasdaq Composite Index 1.59K 0.00% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $27.56M
EBITDA: $-42.57M
Book Value: $-1.21
Earnings/Share: $-1.69
Profit Margin: -245.68%
Operating Margin: -78.00%
ROA (TTM): -27.38%
ROE (TTM): -6,367.24%
Revenue (TTM): $18.67M
Revenue/Share (TTM): $0.66
Earnings Growth (YOY): -61.30%
Revenue Growth (YOY): -5.30%

Valuation Metrics

Enterprise Value: $62.99M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 32.45M
Shares Float: 22.37M
% Insiders: 33.27%
% Institutions: 11.39%
Shares Short: 441.80K
Shares Short (Prior Month): 391.28K
Short Ratio: 3.17
Short % Float: 4.35%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$26.55M
Cost of Goods Sold
adjust
$-20.07M
Gross Profit
subtotal
$6.48M
SG&A
adjust
$-51.27M
R&D
adjust
$-15.03M
Other Operating Expense
adjust
$-1.49M
Operating Income
subtotal
$-61.31M
Other / Non-Operating Items
adjust
$-30.41M
Net Income
subtotal
$-91.72M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CELU.US!